Business ❯ Finance ❯ Stock Market ❯ Pharmaceutical Stocks

Pfizer

Pfizer–Trump Drug-Pricing Deal and ‘TrumpRx’ Plan Jolt Health-Care Stocks Higher

The agreement links Medicaid price cuts to a three-year tariff reprieve for Pfizer, signaling clearer policy direction.

White House Secures Pfizer Deal on Drug Prices With TrumpRx Discounts and $70 Billion U.S. Investment

Pfizer Beats Q2 Estimates and Raises 2025 Profit Forecast